Two doses of the SARS-CoV-2 BNT162b2 vaccine enhance antibody responses to variants in individuals with prior SARS-CoV-2 infection. (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1126/scitranslmed.abj0847
PubMed Identifier: 34376569
Publication URI: http://europepmc.org/abstract/MED/34376569
Type: Journal Article/Review
Volume: 13
Parent Publication: Science translational medicine
Issue: 609
ISSN: 1946-6234